Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction
Shouwen Zhang, Jingfang Li, Shunpeng Hu, Fangfang Wu, Xianzhao Zhang Department of Cardiology, Linyi People’s Hospital, Linyi, People’s Republic of China Background: Cardiovascular diseases (CVDs) are the leading causes of mortality worldwide. Currently, the best treatment opti...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/aae911242e3145209626f75dfcd8f370 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:aae911242e3145209626f75dfcd8f370 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:aae911242e3145209626f75dfcd8f3702021-12-02T10:38:05ZTriphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction1178-2013https://doaj.org/article/aae911242e3145209626f75dfcd8f3702018-07-01T00:00:00Zhttps://www.dovepress.com/triphenylphosphonium-and-d-alpha-tocopheryl-polyethylene-glycol-1000-s-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Shouwen Zhang, Jingfang Li, Shunpeng Hu, Fangfang Wu, Xianzhao Zhang Department of Cardiology, Linyi People’s Hospital, Linyi, People’s Republic of China Background: Cardiovascular diseases (CVDs) are the leading causes of mortality worldwide. Currently, the best treatment options for myocardial infarction focus on the restoration of blood flow as soon as possible, which include reperfusion therapy, percutaneous coronary intervention, and therapeutic thrombolytic drugs.Materials and methods: In the present study, we report the development of lipid-polymeric nanocarriers (LPNs) for mitochondria-targeted delivery of tanshinone IIA (TN). D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) was linked to the triphenylphosphonium (TPP) cation. The LPNs were fabricated by nanoprecipitation method. LPNs were evaluated in vitro and in vivo in comparison with free drugs and other similar nanocarriers.Results: The mean diameter of TN/nanoparticles (NPs) was 89.6 nm, while that of TN/LPNs was 121.3 nm. The zeta potential of TN/NPs and TN/LPNs was –33.6 and –22.3 mV, respectively. Compared with free TN and TN/NPs, TN/LPNs exhibited significantly improved compatibility and therapeutic efficiency. In addition, the in vivo pharmacokinetics, biodistribution, and infarct therapy studies in Sprague Dawley rats showed that TPP-TPGS/TN/LPNs had better efficiency than their nonmodified TN/LPNs counterparts in all respects.Conclusion: These results indicated that the TPP-TPGS/TN/LPNs were promising nanocarriers for efficient delivery of cardiovascular drugs and other therapeutic agents for the treatment of CVDs. Keywords: myocardial infarction, mitochondria targeting, lipid-polymeric nanocarriers, D-α-tocopheryl polyethylene glycol 1000 succinate, triphenylphosphonium, tanshinone IIAZhang SLi JHu SWu FZhang XDove Medical PressarticleMyocardial infarctionmitochondria targetinglipid-polymeric nanocarriersD-α-tocopheryl polyethylene glycol 1000 succinatetriphenylphosphoniumTanshinone IIAMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 4045-4057 (2018) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Myocardial infarction mitochondria targeting lipid-polymeric nanocarriers D-α-tocopheryl polyethylene glycol 1000 succinate triphenylphosphonium Tanshinone IIA Medicine (General) R5-920 |
| spellingShingle |
Myocardial infarction mitochondria targeting lipid-polymeric nanocarriers D-α-tocopheryl polyethylene glycol 1000 succinate triphenylphosphonium Tanshinone IIA Medicine (General) R5-920 Zhang S Li J Hu S Wu F Zhang X Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction |
| description |
Shouwen Zhang, Jingfang Li, Shunpeng Hu, Fangfang Wu, Xianzhao Zhang Department of Cardiology, Linyi People’s Hospital, Linyi, People’s Republic of China Background: Cardiovascular diseases (CVDs) are the leading causes of mortality worldwide. Currently, the best treatment options for myocardial infarction focus on the restoration of blood flow as soon as possible, which include reperfusion therapy, percutaneous coronary intervention, and therapeutic thrombolytic drugs.Materials and methods: In the present study, we report the development of lipid-polymeric nanocarriers (LPNs) for mitochondria-targeted delivery of tanshinone IIA (TN). D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) was linked to the triphenylphosphonium (TPP) cation. The LPNs were fabricated by nanoprecipitation method. LPNs were evaluated in vitro and in vivo in comparison with free drugs and other similar nanocarriers.Results: The mean diameter of TN/nanoparticles (NPs) was 89.6 nm, while that of TN/LPNs was 121.3 nm. The zeta potential of TN/NPs and TN/LPNs was –33.6 and –22.3 mV, respectively. Compared with free TN and TN/NPs, TN/LPNs exhibited significantly improved compatibility and therapeutic efficiency. In addition, the in vivo pharmacokinetics, biodistribution, and infarct therapy studies in Sprague Dawley rats showed that TPP-TPGS/TN/LPNs had better efficiency than their nonmodified TN/LPNs counterparts in all respects.Conclusion: These results indicated that the TPP-TPGS/TN/LPNs were promising nanocarriers for efficient delivery of cardiovascular drugs and other therapeutic agents for the treatment of CVDs. Keywords: myocardial infarction, mitochondria targeting, lipid-polymeric nanocarriers, D-α-tocopheryl polyethylene glycol 1000 succinate, triphenylphosphonium, tanshinone IIA |
| format |
article |
| author |
Zhang S Li J Hu S Wu F Zhang X |
| author_facet |
Zhang S Li J Hu S Wu F Zhang X |
| author_sort |
Zhang S |
| title |
Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction |
| title_short |
Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction |
| title_full |
Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction |
| title_fullStr |
Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction |
| title_full_unstemmed |
Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction |
| title_sort |
triphenylphosphonium and d-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone iia-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction |
| publisher |
Dove Medical Press |
| publishDate |
2018 |
| url |
https://doaj.org/article/aae911242e3145209626f75dfcd8f370 |
| work_keys_str_mv |
AT zhangs triphenylphosphoniumanddalphatocopherylpolyethyleneglycol1000succinatemodifiedtanshinoneiialoadedlipidpolymericnanocarriersforthetargetedtherapyofmyocardialinfarction AT lij triphenylphosphoniumanddalphatocopherylpolyethyleneglycol1000succinatemodifiedtanshinoneiialoadedlipidpolymericnanocarriersforthetargetedtherapyofmyocardialinfarction AT hus triphenylphosphoniumanddalphatocopherylpolyethyleneglycol1000succinatemodifiedtanshinoneiialoadedlipidpolymericnanocarriersforthetargetedtherapyofmyocardialinfarction AT wuf triphenylphosphoniumanddalphatocopherylpolyethyleneglycol1000succinatemodifiedtanshinoneiialoadedlipidpolymericnanocarriersforthetargetedtherapyofmyocardialinfarction AT zhangx triphenylphosphoniumanddalphatocopherylpolyethyleneglycol1000succinatemodifiedtanshinoneiialoadedlipidpolymericnanocarriersforthetargetedtherapyofmyocardialinfarction |
| _version_ |
1718396957377953792 |